Skip to Main content Skip to Navigation
Journal articles

Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants

Abstract : Introduction Lupus Anticoagulant testing using dilute Russell Viper Venom Time (dRVVT) is challenging in patients receiving Direct Oral AntiCoagulants (DOAC) due to potential false positive results. In a multicenter study, we evaluated the in vitro removal of DOAC by activated charcoal (DOAC remove®), allowing reliable dRVVT testing. Materials and methods Patient samples were analyzed before and after treatment with DOAC remove® 49 apixaban, 48 rivaroxaban, 24 dabigatran and 30 none. DOAC plasma concentrations were measured using anti-Xa or diluted thrombin time assays. In a subset of 28 samples, DOAC concentrations were also measured using HPLC-MS/MS following treatment with DOAC remove®. DRVVT was performed using STA-Staclot dRVVT Screen®/Confirm® (Stago) or LAC-Screening®/Confirmation® (Siemens). Results Baseline median [min-max] concentrations were 94 [<20–479] for apixaban, 107 [<20–501] for rivaroxaban and 135 ng/mL [<20–792] for dabigatran; dRVVT screen ratio/confirm ratio was positive in 47, 90 and 42% of apixaban, rivaroxaban and dabigatran samples. Treatment with DOAC remove® did not affect dRVVT results in non-DOAC patients while it resulted in DOAC concentrations <20 ng/mL in 82, 98 and 100% of samples, respectively. Concentrations were <5 ng/mL with HPLC-MS/MS in 5 out of 10, 8 out of 10 and 7 out of 8 samples, respectively. DOAC remove® corrected DOAC interference with dRVVT assays in 76, 85 and 95% of the patients, respectively. Conclusion For dRVVT testing in DOAC patients, we suggest the use of DOAC remove® for every rivaroxaban sample, whereas it might only be used in positive apixaban and dabigatran samples. A residual DOAC interference cannot be ruled out in case of persisting dRVVT positive results after treatment with DOAC remove®. © 2019 Elsevier Ltd
Document type :
Journal articles
Complete list of metadatas

Cited literature [35 references]  Display  Hide  Download

https://hal-univ-rennes1.archives-ouvertes.fr/hal-02397750
Contributor : Laurent Jonchère <>
Submitted on : Friday, March 20, 2020 - 10:23:02 AM
Last modification on : Friday, April 17, 2020 - 2:30:05 PM
Long-term archiving on: : Sunday, June 21, 2020 - 12:51:32 PM

File

Jourdi et al-2019-Potential us...
Files produced by the author(s)

Identifiers

Citation

G. Jourdi, M. Delrue, A. Stepanian, J. Valaize, G. Foulon-Pinto, et al.. Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants. Thrombosis Research, Elsevier, 2019, 184, pp.86-91. ⟨10.1016/j.thromres.2019.11.001⟩. ⟨hal-02397750⟩

Share

Metrics

Record views

305

Files downloads

444